Exact Mass: 285.1801

Exact Mass Matches: 285.1801

Found 78 metabolites which its exact mass value is equals to given mass value 285.1801, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mepyramine

N-[(4-Methoxyphenyl)methyl]-n,n-dimethyl-N-2-pyridinyl-1,2-ethanediamine

C17H23N3O (285.1841)


Mepyramine (also known as pyrilamine) is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect. It is used in over-the-counter combination products for colds and menstrual symptoms. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 3006 D018926 - Anti-Allergic Agents

   

Isococculidine

Isococculidine; Erythrinan, 1,2-didehydro-3,15-dimethoxy-, (3-beta)-

C18H23NO2 (285.1729)


   

(1R,9S)-10-(Cyclopropylmethyl)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one

(1R,9S)-10-(Cyclopropylmethyl)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one

C18H23NO2 (285.1729)


   
   
   

MEGxp0_001126

MEGxp0_001126

C18H23NO2 (285.1729)


   
   

1-(benzylamino)-3-(3,4-dimethylphenoxy)propan-2-ol

1-(benzylamino)-3-(3,4-dimethylphenoxy)propan-2-ol

C18H23NO2 (285.1729)


   

SCHEMBL2182422

SCHEMBL2182422

C18H23NO2 (285.1729)


   

8-Aza-D-homo-oestron

8-Aza-D-homo-oestron

C18H23NO2 (285.1729)


   

3,5-Hexalobine E

3,5-Hexalobine E

C18H23NO2 (285.1729)


   

3,6-Di-(2,3-epoxy-3-methylbutyl)-indol|ent-3,6-hexalobine C

3,6-Di-(2,3-epoxy-3-methylbutyl)-indol|ent-3,6-hexalobine C

C18H23NO2 (285.1729)


   

Glycosmisindole

Glycosmisindole

C18H23NO2 (285.1729)


   

2,3-Hexalobine E

2,3-Hexalobine E

C18H23NO2 (285.1729)


   

3,6-(E)-hexalobine E

3,6-(E)-hexalobine E

C18H23NO2 (285.1729)


   
   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-3-methyl-2-butenamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-3-methyl-2-butenamide

C18H23NO2 (285.1729)


   

Oxime-8alpha-Estrone,INN

Oxime-8alpha-Estrone,INN

C18H23NO2 (285.1729)


   

PSN375963

4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine

C17H23N3O (285.1841)


   

pyrilamine

PYR_286.1915_11.5

C17H23N3O (285.1841)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1700

   

octylphenazolone

octylphenazolone

C18H23NO2 (285.1729)


   

Bifemelane M1

Bifemelane M1

C18H23NO2 (285.1729)


   

Hydroxybifemelane (M2)

Hydroxybifemelane (M2)

C18H23NO2 (285.1729)


   

3-[[2-(dimethylamino)ethoxy](2-methylphenyl)methyl]-Phenol

3-[[2-(dimethylamino)ethoxy](2-methylphenyl)methyl]-Phenol

C18H23NO2 (285.1729)


   

p-Cresol, a-[2-(dimethylamino)ethoxy]-a-o-tolyl-

p-Cresol, a-[2-(dimethylamino)ethoxy]-a-o-tolyl-

C18H23NO2 (285.1729)


   

3-[[2-(dimethylamino)ethoxy]phenylmethyl]-4-methyl-Phenol

3-[[2-(dimethylamino)ethoxy]phenylmethyl]-4-methyl-Phenol

C18H23NO2 (285.1729)


   

Orphenadrine N-oxide

Orphenadrine N-oxide

C18H23NO2 (285.1729)


   

N,N,N-Tripropyl-1-propanaminium perchlorate

N,N,N-Tripropyl-1-propanaminium perchlorate

C12H28ClNO4 (285.1707)


   

medrylamine

medrylamine

C18H23NO2 (285.1729)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

ISOPROPYL 3-CYCLOPENTYL-1-METHYL-1H-INDOLE-6-CARBOXYLATE

ISOPROPYL 3-CYCLOPENTYL-1-METHYL-1H-INDOLE-6-CARBOXYLATE

C18H23NO2 (285.1729)


   
   
   

PHENOL, 2-(1,1-DIMETHYLETHYL)-6-(1-METHYLETHYL)-4-(3-PYRIDAZINYLAMINO)-

PHENOL, 2-(1,1-DIMETHYLETHYL)-6-(1-METHYLETHYL)-4-(3-PYRIDAZINYLAMINO)-

C17H23N3O (285.1841)


   

ETHYL 5-(TERT-BUTYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE

ETHYL 5-(TERT-BUTYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE

C18H23NO2 (285.1729)


   

1-Boc-4-phenylethynyl-piperidine

1-Boc-4-phenylethynyl-piperidine

C18H23NO2 (285.1729)


   

1-Benzyl-4-morpholinopiperidine-4-carbonitrile

1-Benzyl-4-morpholinopiperidine-4-carbonitrile

C17H23N3O (285.1841)


   

N-benzyl-2-(3,4-dimethoxyphenyl)-N-methylethanamine

N-benzyl-2-(3,4-dimethoxyphenyl)-N-methylethanamine

C18H23NO2 (285.1729)


   

tert-Butyl spiro[indene-1,4-piperidine]-1-carboxylate

tert-Butyl spiro[indene-1,4-piperidine]-1-carboxylate

C18H23NO2 (285.1729)


   

citral / methyl anthranilate schiffs base

citral / methyl anthranilate schiffs base

C18H23NO2 (285.1729)


   

N-Methyl-N-(2-(4-aminophenoxy)ethyl)-2-(4-aminophenyl)ethanamine

N-Methyl-N-(2-(4-aminophenoxy)ethyl)-2-(4-aminophenyl)ethanamine

C17H23N3O (285.1841)


   
   
   
   
   

9-oxo-N-(1-phenylethyl)bicyclo[3.3.1]nonane-3-carboxamide

9-oxo-N-(1-phenylethyl)bicyclo[3.3.1]nonane-3-carboxamide

C18H23NO2 (285.1729)


   

1-(2-Ethyl-3-benzofuranyl)-3-(1-piperidinyl)-1-propanone

1-(2-Ethyl-3-benzofuranyl)-3-(1-piperidinyl)-1-propanone

C18H23NO2 (285.1729)


   

(E)-1-hydroxy-2-(non-1-en-1-yl)quinolin-4-one

(E)-1-hydroxy-2-(non-1-en-1-yl)quinolin-4-one

C18H23NO2 (285.1729)


A hydroxylamine that is N-hydroxyquinolin-4-one in which the hydrogen at position 2 has been replaced by a (1E)-non-1-en-1-yl group. It is the most active agent produced by Pseudomonas aeruginosa that modulates the growth and virulence of Staphylococcus aureus; the corresponding Z isomer is inactive.

   

4-[Methyl-(phenylmethyl)amino]-1-phenylbutane-1,3-diol

4-[Methyl-(phenylmethyl)amino]-1-phenylbutane-1,3-diol

C18H23NO2 (285.1729)


   

(2s,3s,4r)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-yl acetate

(2s,3s,4r)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-yl acetate

C18H23NO2 (285.1729)


   

(9bs,11s)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline

(9bs,11s)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline

C18H23NO2 (285.1729)


   

3,6-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

3,6-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

C18H23NO2 (285.1729)


   

3,3-bis(but-3-en-1-yl)-4-methoxy-4h-quinolin-2-ol

3,3-bis(but-3-en-1-yl)-4-methoxy-4h-quinolin-2-ol

C18H23NO2 (285.1729)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-3-methylbut-2-enimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-3-methylbut-2-enimidic acid

C18H23NO2 (285.1729)


   

2-(nonan-8-one)-(1h)-4-quinolone

NA

C18H23NO2 (285.1729)


{"Ingredient_id": "HBIN006129","Ingredient_name": "2-(nonan-8-one)-(1h)-4-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15682","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3,3-dimethylallyl-4-methoxy-2-quinolone

NA

C18H23NO2 (285.1729)


{"Ingredient_id": "HBIN007181","Ingredient_name": "3,3-dimethylallyl-4-methoxy-2-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15154","TCMID_id": "6307","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-dimethylallyl-4-methoxy-2-quinolone

NA

C18H23NO2 (285.1729)


{"Ingredient_id": "HBIN008441","Ingredient_name": "3-dimethylallyl-4-methoxy-2-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25844","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline

8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline

C18H23NO2 (285.1729)


   

3,5-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

3,5-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

C18H23NO2 (285.1729)


   

(4e,7e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

(4e,7e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-2-yl)-2-methylbut-3-en-2-ol

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-2-yl)-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

3,6-bis({[(2s)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

3,6-bis({[(2s)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

C18H23NO2 (285.1729)


   

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indole

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indole

C18H23NO2 (285.1729)


   

3,5-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole

3,5-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole

C18H23NO2 (285.1729)


   

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-6-yl}-2-methylbut-3-en-2-ol

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-6-yl}-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-5-yl}-2-methylbut-3-en-2-ol

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-5-yl}-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-5-yl)-2-methylbut-3-en-2-ol

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-5-yl)-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

3,6-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole

3,6-bis[(3,3-dimethyloxiran-2-yl)methyl]-1h-indole

C18H23NO2 (285.1729)


   

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-2-yl}-2-methylbut-3-en-2-ol

4-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-2-yl}-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

(3z)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol

(3z)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol

(3e)-4-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-6-yl)-2-methylbut-3-en-2-ol

C18H23NO2 (285.1729)


   

(4e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

(4e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

4,15-dimethoxy-10-azatetracyclo[8.6.1.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,13-tetraene

4,15-dimethoxy-10-azatetracyclo[8.6.1.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,13-tetraene

C18H23NO2 (285.1729)


   

(9bs,11r,13as)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline

(9bs,11r,13as)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline

C18H23NO2 (285.1729)


   

8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline

8,11-dimethoxy-1h,2h,4h,5h,10h,11h,13ah-indolo[7a,1-a]isoquinoline

C18H23NO2 (285.1729)


   

2-(8-oxononyl)-1h-quinolin-4-one

2-(8-oxononyl)-1h-quinolin-4-one

C18H23NO2 (285.1729)